Alzheimer's disease (AD) is a neurodegenerative disorder linked to cognitive decline. Type 2 diabetes mellitus (T2DM) is a known risk factor for AD and may contribute to cerebellar atrophy, but their relationship remains unclear.
Objective
This study investigated the impact of T2DM on cerebellar gray matter (GM) volume across normal cognition (NC), preclinical AD, and AD mild cognitive impairment (AD MCI) groups to explore its role in AD progression.
Methods
Medical records of patients visiting St. Vincent's Hospital (September 2019–April 2024) were analyzed. Cerebellar GM volume was analyzed using voxel-based morphometry with SPM12. Group differences in cerebellar GM volume were assessed using rank analysis of covariance. Spearman's partial correlation was used to explore associations between cerebellar GM volume and cognitive function, and HbA1c levels in patients with T2DM.
Results
AD MCI patients with T2DM showed greater GM atrophy, particularly in the posterior lobe. In NC, T2DM was associated with Vermis VI volume reduction, while preclinical AD showed increased Left VIIIb volume. Amyloid-β positive (Aβ+) group has negative correlation HbA1c level and right Crus I volume. Cerebellar GM volume correlated with cognitive scores, particularly episodic memory in AD MCI patients with T2DM.
Conclusions
T2DM and AD pathology contribute to cerebellar changes linked to cognitive decline. Managing T2DM may mitigate its impact on AD progression.
BraakHBraakE. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol1991; 82: 239–259.
2.
FelicianOSandsonTA. The neurobiology and pharmacotherapy of Alzheimer's disease. J Neuropsychiatry Clin Neurosci1999; 11: 19–31.
3.
EdwardsGAIIIGamezNEscobedoGJr, et al.Modifiable risk factors for Alzheimer’s disease. Front Aging Neurosci2019; 11: 146.
4.
BarbagalloMDominguezLJ. Type 2 diabetes mellitus and Alzheimer's disease. World J Diabetes2014; 5: 889–893.
5.
BiesselsGJDespaF. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol2018; 14: 591–604.
6.
AkomolafeABeiserAMeigsJB, et al.Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham study. Arch Neurol2006; 63: 1551–1555.
7.
HoenigMCBischofGNSeemillerJ, et al.Networks of tau distribution in Alzheimer’s disease. Brain2018; 141: 568–581.
8.
TonioloSSerraLOlivitoG, et al.Patterns of cerebellar gray matter atrophy across Alzheimer’s disease progression. Front Cell Neurosci2018; 12: 430.
9.
OhDJJungJ-JShinSA, et al.Brain structural alterations, diabetes biomarkers, and cognitive performance in older adults with dysglycemia. Front Neurol2021; 12: 766216.
10.
StoodleyCJSchmahmannJD. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex2010; 46: 831–844.
11.
LinC-YChenC-HTomSE, et al.Cerebellar volume is associated with cognitive decline in mild cognitive impairment: results from ADNI. Cerebellum2020; 19: 217–225.
12.
HabasC. Functional connectivity of the cognitive cerebellum. Front Syst Neurosci2021; 15: 642225.
13.
HabasCKamdarNNguyenD, et al.Distinct cerebellar contributions to intrinsic connectivity networks. J Neurosci2009; 29: 8586–8594.
14.
BrissendenJALevinEJOsherDE, et al.Functional evidence for a cerebellar node of the dorsal attention network. J Neurosci2016; 36: 6083–6096.
15.
DiedrichsenJKingMHernandez-CastilloC, et al.Universal transform or multiple functionality? Understanding the contribution of the human cerebellum across task domains. Neuron2019; 102: 918–928.
16.
SpulberGNiskanenEMacDonaldS, et al.Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. Curr Alzheimer Res2012; 9: 516–524.
17.
SerraLCercignaniMMastropasquaC, et al.Longitudinal changes in functional brain connectivity predicts conversion to Alzheimer’s disease. J Alzheimers Dis2016; 51: 377–389.
18.
QiuWQFolsteinMF. Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis. Neurobiol Aging2006; 27: 190–198.
19.
CraftSWatsonGS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol2004; 3: 169–178.
20.
AkterKLanzaEAMartinSA, et al.Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?Br J Clin Pharmacol2011; 71: 365–376.
21.
StrachanMWReynoldsRMMarioniRE, et al.Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol2011; 7: 108–114.
22.
ZhangDQiFGaoJ, et al.Altered cerebellar-cerebral circuits in patients with type 2 diabetes mellitus. Front Neurosci2020; 14: 571210.
23.
KimTHJhooJHParkJH, et al.Korean Version of mini mental status examination for dementia screening and its’ short form. Psychiatry Investig2010; 7: 102.
24.
LeeJHLeeKULeeDY, et al.Development of the Korean version of the consortium to establish a registry for Alzheimer's disease assessment packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci2002; 57: P47–P53.
25.
ChoiSHNaDLLeeBH, et al.The validity of the Korean version of global deterioration scale. J Korean Neurol Assoc2002; 20: 612–617.
26.
ChoiSHNaDLLeeBH, et al.Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale. J Korean Neurol Assoc2001; 19: 585–591.
27.
WonCWYangKYRhoYG, et al.The development of Korean activities of daily living (K-ADL) and Korean instrumental activities of daily living (K-IADL) scale. Ann Geriatr Med Res2002; 6: 107–120.
28.
ChoiSHNaDLKwonHM, et al.The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients. J Korean Med Sci2000; 15: 609–615.
29.
PetersenRCDoodyRKurzA, et al.Current concepts in mild cognitive impairment. Arch Neurol2001; 58: 1985–1992.
30.
DiedrichsenJBalstersJHFlavellJ, et al.A probabilistic MR atlas of the human cerebellum. Neuroimage2009; 46: 39–46.
31.
GaserCDahnkeRThompsonPM, et al.CAT: a computational anatomy toolbox for the analysis of structural MRI data. GigaScience2024; 13: giae049.
32.
D'MelloAMStoodleyCJ. Cerebro-cerebellar circuits in autism spectrum disorder. Front Neurosci2015; 9: 408.
33.
NaSSeoSWKimYJ, et al.Correlation analysis between subtest scores of CERAD-K and a newly developed tablet computer-based digital cognitive test (inbrain CST). Front Aging Neurosci2023; 15: 1178324.
34.
ThomannPASchläferCSeidlU, et al.The cerebellum in mild cognitive impairment and Alzheimer’s disease–A structural MRI study. J Psychiatr Res2008; 42: 1198–1202.
35.
ChenXGarelickMGWangH, et al.PI3 Kinase signaling is required for retrieval and extinction of contextual memory. Nat Neurosci2005; 8: 925–931.
36.
ChiangH-CWangLXieZ, et al.PI3 Kinase signaling is involved in aβ-induced memory loss in Drosophila. Proc Natl Acad Sci U S A2010; 107: 7060–7065.
37.
HorwoodJMDufourFLarocheS, et al.Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci2006; 23: 3375–3384.
38.
AdamoMRaizadaMKLeRoithD. Insulin and insulin-like growth factor receptors in the nervous system. Mol Neurobiol1989; 3: 71–100.
39.
UngerJWLivingstonJNMossAM. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol1991; 36: 343–362.
40.
MushtaqGKhanJAKumosaniTA, et al.Alzheimer’s disease and type 2 diabetes via chronic inflammatory mechanisms. Saudi J Biol Sci2015; 22: 4–13.
41.
PradhanADMansonJERifaiN, et al.C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA2001; 286: 327–334.
42.
FillitHDingWBueeL, et al.Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett1991; 129: 318–320.
43.
BruunsgaardHAndersen-RanbergKJeuneB, et al.A high plasma concentration of TNF-α is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci1999; 54: M357–M364.
44.
WangFGuoXShenX, et al.Vascular dysfunction associated with type 2 diabetes and Alzheimer’s disease: a potential etiological linkage. Med Sci Monit Basic Res2014; 20: 118.
45.
LiangNNhoKNewmanJW, et al.Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer’s disease. Sci Rep2024; 14: 17423.
46.
ChambersWSpragueJM. Functional localization in the cerebellum. I. Organization in longitudinal cortico-nuclear zones and their contribution to the control of posture, both extrapyramidal and pyramidal. J Comp Neurol1955; 103: 105–129.
47.
CoffmanKADumRPStrickPL. Cerebellar vermis is a target of projections from the motor areas in the cerebral cortex. Proc Natl Acad Sci U S A2011; 108: 16068–16073.
48.
PetrofskyJLeeSBweirS. Gait characteristics in people with type 2 diabetes mellitus. Eur J Appl Physiol2005; 93: 640–647.
49.
GuoL-HAlexopoulosPWagenpfeilS, et al.Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study. Alzheimers Dement2013; 9: 580–586.
50.
WangZLiangPJiaX, et al.The baseline and longitudinal changes of PCC connectivity in mild cognitive impairment: a combined structure and resting-state fMRI study. PloS One2012; 7: e36838.
51.
AlexopoulosPSorgCFörschlerA, et al.Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI. Eur Arch Psychiatry Clin Neurosci2012; 262: 69–77.
52.
GongDHeHLiuD, et al.Enhanced functional connectivity and increased gray matter volume of insula related to action video game playing. Sci Rep2015; 5: 9763.
53.
GellersenHMGuoCCO’CallaghanC, et al.Cerebellar atrophy in neurodegeneration—A meta-analysis. J Neurol Neurosurg Psychiatry2017; 88: 780–788.
54.
ChenYKumforFLandin-RomeroR, et al.The cerebellum in frontotemporal dementia: a meta-analysis of neuroimaging studies. Neuropsychol Rev2019; 29: 450–464.
55.
ZhangH-YShenGYangC, et al.The reduced gray matter volume and functional connectivity of the cerebellum in type 2 diabetes mellitus with high insulin resistance. Neuroendocrinology2024; 114: 386–399.
56.
ParkSEParkCYSweeneyG. Biomarkers of insulin sensitivity and insulin resistance: past, present and future. Crit Rev Clin Lab Sci2015; 52: 180–190.
57.
BrissendenJASomersDC. Cortico–cerebellar networks for visual attention and working memory. Curr Opin Psychol2019; 29: 239–247.
58.
KoppelmansVHoogendamYYHirsigerS, et al.Regional cerebellar volumetric correlates of manual motor and cognitive function. Brain Struct Funct2017; 222: 1929–1944.
59.
MoghaddamHSSherbafFGAarabiMH. Brain microstructural abnormalities in type 2 diabetes mellitus: a systematic review of diffusion tensor imaging studies. Front Neuroendocrinol2019; 55: 100782.
60.
BucknerRLAndrews-HannaJRSchacterDL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci2008; 1124: 1–38.
61.
GriederMWangDJDierksT, et al.Default mode network complexity and cognitive decline in mild Alzheimer’s disease. Front Neurosci2018; 12: 770.
62.
YangS-QXuZ-PXiongY, et al.Altered intranetwork and internetwork functional connectivity in type 2 diabetes mellitus with and without cognitive impairment. Sci Rep2016; 6: 32980.
63.
MusenGJacobsonAMBoloNR, et al.Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes2012; 61: 2375–2379.
64.
ChoiYHBahnYKLimHS, et al.A discussion on image analysis in 18 F-florbetaben PET/CT. Korean J Nucl Med Technol2022; 26: 33–37.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
